📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Neovasc

1.1 - Company Overview

Neovasc Logo

Neovasc

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty cardiovascular medical devices and services, developing and manufacturing products for the cardiovascular device marketplace. Offers pericardial tissue processing and vascular product development, design, and manufacturing solutions to industry partners. Products include the Reducer device for treating refractory angina, supported by clinical studies evaluating its safety and effectiveness.

Products and services

  • Shockwave Reducer: Coronary-sinus-targeted device engineered to treat refractory angina by creating controlled narrowing, increasing back pressure and redistributing blood to ischemic myocardium
  • COSIRA Prospective Randomized Study: Initial prospective-randomized clinical trial that demonstrated the Reducer’s safety and effectiveness, improving angina symptoms and quality of life for patients with refractory angina
  • COSIRA-II Multi-Center Study: Multi-center study aimed at gathering further evidence on the Reducer system’s safety and effectiveness for treating refractory angina

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Neovasc

Caliber Therapeutics Logo

Caliber Therapeutics

HQ: United States Website
  • Description: Provider of stent-free targeted angioplasty drug delivery solutions, featuring the Virtue Sirolimus AngioInfusion Balloon, an investigational drug/device delivering extended-release sirolimus during balloon angioplasty without coating or permanent implant, and BackBeat Cardiac Neuromodulation Therapy, an investigational bioelectronic treatment for hypertension that modulates autonomic nervous system responses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caliber Therapeutics company profile →
Omeicos Logo

Omeicos

HQ: Germany Website
  • Description: Provider of first-in-class small-molecule therapeutics based on omega-3 fatty acid metabolites for the treatment and prevention of atrial fibrillation and broader indications. Offers OMT-28, a synthetic analog of 17,18-EEQ for cardiovascular inflammation and mitochondrial dysfunction; conducts the PMD-OPTION study in Primary Mitochondrial Disease; and develops a pipeline of proprietary omega-3 analogs for cardiovascular, inflammatory, and mitochondrial diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Omeicos company profile →
Nectero Medical Logo

Nectero Medical

HQ: United States Website
  • Description: Provider of a minimally invasive treatment to stabilize growth and prevent rupture of small to mid-sized abdominal aortic aneurysms through the Nectero EAST® System, which uses a dual-balloon catheter to deliver a stabilizer mixture to strengthen the aortic wall; includes the stAAAble Trial to evaluate safety and efficacy in patients with infrarenal abdominal aortic aneurysms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nectero Medical company profile →
Aldagen Logo

Aldagen

HQ: United States Website
  • Description: Provider of proprietary regenerative cell therapies addressing inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure. The biopharmaceutical company has four product candidates in clinical trials, including lead candidate ALD-101 in a pivotal Phase 3 trial to evaluate its efficacy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aldagen company profile →
TYRX Logo

TYRX

HQ: United States Website
  • Description: Provider of medical-pharmaceutical combination devices and resorbable polymeric biomaterials delivering site-specific therapy for multiple surgical markets. Offers PIVIT CRM, a mesh-based pouch with antibacterial agents to protect against microbial colonization of the generator or defibrillator during and immediately after surgical implant; also provides AIGISRx.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TYRX company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Neovasc

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Neovasc

2.2 - Growth funds investing in similar companies to Neovasc

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Neovasc

4.2 - Public trading comparable groups for Neovasc

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Neovasc

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Neovasc

What does Neovasc do?

Neovasc is a provider of specialty cardiovascular medical devices and services, developing and manufacturing products for the cardiovascular device marketplace. Offers pericardial tissue processing and vascular product development, design, and manufacturing solutions to industry partners. Products include the Reducer device for treating refractory angina, supported by clinical studies evaluating its safety and effectiveness.

Who are Neovasc's competitors?

Neovasc's competitors and similar companies include Caliber Therapeutics, Omeicos, Nectero Medical, Aldagen, and TYRX.

Where is Neovasc headquartered?

Neovasc is headquartered in Canada.

How many employees does Neovasc have?

Neovasc has 1,000 employees 🔒.

When was Neovasc founded?

Neovasc was founded in 2010 🔒.

What sector and industry vertical is Neovasc in?

Neovasc is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Neovasc

Who are the top strategic acquirers in Neovasc's sector and industry

Top strategic M&A buyers and acquirers in Neovasc's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Neovasc?

Top strategic M&A buyers groups and sectors for Neovasc include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Neovasc's sector and industry vertical

Which are the top PE firms investing in Neovasc's sector and industry vertical?

Top PE firms investing in Neovasc's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Neovasc's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Neovasc's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Neovasc's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Neovasc include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Neovasc's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Neovasc?

The key public trading comparables and valuation benchmarks for Neovasc include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Neovasc for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Neovasc with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Neovasc's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Neovasc with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Neovasc's' sector and industry vertical?

Access recent funding rounds and capital raises in Neovasc's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Neovasc